Even as Congress remains divided over the latest US defence bill, lawmakers in both parties remain united on one issue: China.
The National Defence Authorisation Act (NDAA), which sets US defence policy and authorises military spending each year, reflects a broad bipartisan consensus on expanding Washington’s military, technological and economic rivalry with Beijing.
While the House and Senate versions differ on a number of provisions, both include new measures on Taiwan, artificial intelligence, defence supply chains and preparations for a potential South China Sea crisis, underscoring how competition with Beijing has become embedded throughout US national security policy.
The House has already passed its version of the financial year 2027 NDAA, while the Senate is struggling to approve its own before next week’s August recess. The two chambers will then have to reconcile their differences before sending the legislation to US President Donald Trump for his signature.
This year’s tone is largely the same as in past bills, experts say, though with notable new additions targeting China across a wide range of issues, from defence procurement and supply chains to artificial intelligence, industrial policy and economic security.

Bonnie Glaser, managing director of the German Marshall Fund’s Indo-Pacific programme, said the NDAA had increasingly been used to bolster resilience against China while strengthening defence ties with allies and partners.

Don't Miss:
-
FBI Most Wanted “Chapo Isidro,” Leader of BLO/Guasave Cartel Arrested in Sinaloa, “El Musico” Possibly Killed
-
DEA’s #FugitiveFriday asks for tips on “El Tano” García Corrales, found dead in Sinaloa in 2024
-
Mocorito, Sinaloa: “El Pagador” and “El Chendo” of La FEA, arrested again 15 months after walking free
-
Zapopan: Marines arrest “El Topo,” alleged Los Deltas leader linked to journalist’s kidnapping; three gunmen killed
-
Anabel Hernández claims “El Mayito Gordo” is back in Mexico, fighting Los Chapitos from the Durango sierra

Trump Enjoyed His Asian Spectacle. He Came Home Empty-Handed
Medical device makers have gotten worse at disclosing when their products harm people, new study finds. The FDA let them.
Anatomy of a Chinese loanbook